title: Selective activation of dorsal raphe nucleus-projecting neurons in the ventral medial prefrontal cortex by controllable stress.
abstract: Exposure to uncontrollable stressors produces a variety of behavioral consequences (e.g. exaggerated fear, reduced social exploration) that do not occur if the stressor is controllable. In addition, an initial experience with a controllable stressor can block the behavioral and neural responses to a later uncontrollable stressor. The serotonergic (5-HT) dorsal raphe nucleus (DRN) has come to be viewed as a critical structure in mediating the behavioral effects of uncontrollable stress. Recent work suggests that the buffering effects of behavioral control on the DRN-dependent behavioral outcomes of uncontrollable stress require ventral medial prefrontal cortex (mPFCv) activation at the time of behavioral control. The present studies were conducted to directly determine whether or not controllable stress selectively activates DRN-projecting neurons within the mPFCv. To examine this possibility in the rat, we combined retrograde tracing (fluorogold iontophoresed into the DRN) with Fos immunohistochemistry, a marker for neural activation. Exposure to controllable, relative to uncontrollable, stress increased Fos expression in fluorogold-labeled neurons in the prelimbic region (PL) of the mPFCv. Furthermore, in a separate experiment, a prior experience with controllable stress led to potentiation of Fos expression in retrogradely labeled PL neurons in response to an uncontrollable stressor 1 week later. These results suggest that the PL selectively responds to behavioral control and utilizes such information to regulate the brainstem response to ongoing and subsequent stressors.
authors.affiliation: Department of Psychology, University of Colorado at Boulder, Boulder, CO 80309-0345, USA. baratta@mit.edu
authors.forename: Michael V
authors.initials: MV
authors.lastname: Baratta
authors.forename: Christina M
authors.initials: CM
authors.lastname: Zarza
authors.forename: Devan M
authors.initials: DM
authors.lastname: Gomez
authors.forename: Serge
authors.initials: S
authors.lastname: Campeau
authors.forename: Linda R
authors.initials: LR
authors.lastname: Watkins
authors.forename: Steven F
authors.initials: SF
authors.lastname: Maier
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal; D004597:Electroshock; D005456:Fluorescent Dyes; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D008297:Male; D009434:Neural Pathways / Q000378:metabolism / Q000502:physiology; D009474:Neurons / Q000378:metabolism / Q000502:physiology*; D017397:Prefrontal Cortex / Q000378:metabolism / Q000502:physiology*; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D011903:Raphe Nuclei / Q000378:metabolism / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013312:Stress, Physiological / Q000502:physiology*
chemical_list: D005456:Fluorescent Dyes; D016760:Proto-Oncogene Proteins c-fos
references.citation: Brain Res. 1998 Nov 23;812(1-2):113-20
references.pmid: 9813270
references.citation: J Comp Neurol. 1989 Dec 8;290(2):213-42
references.pmid: 2592611
references.citation: Neuroscience. 2001;106(4):783-92
references.pmid: 11682163
references.citation: Am J Psychiatry. 1998 May;155(5):630-7
references.pmid: 9585714
references.citation: Neuroscience. 2007 Jun 8;146(4):1495-503
references.pmid: 17478046
references.citation: Synapse. 2004 Jan;51(1):32-58
references.pmid: 14579424
references.citation: J Comp Neurol. 2005 Jan 10;481(2):179-93
references.pmid: 15562508
references.citation: Neuroscience. 1998 Nov;87(1):95-108
references.pmid: 9722144
references.citation: J Comp Physiol Psychol. 1968 Apr;65(2):251-60
references.pmid: 5668311
references.citation: Neuropsychopharmacology. 2009 Mar;34(4):834-43
references.pmid: 18368036
references.citation: Brain Res. 1999 Apr 24;826(1):35-43
references.pmid: 10216194
references.citation: Brain Res. 1997 Sep 12;768(1-2):327-32
references.pmid: 9369332
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):829-41
references.pmid: 15893820
references.citation: Nat Neurosci. 2005 Mar;8(3):365-71
references.pmid: 15696163
references.citation: Neuropsychopharmacology. 1988 Dec;1(4):287-95
references.pmid: 2908021
references.citation: J Neurosci. 2006 Dec 20;26(51):13264-72
references.pmid: 17182776
references.citation: Brain Res Bull. 1992 Dec;29(6):943-8
references.pmid: 1473026
references.citation: J Neurosci Methods. 1980 Dec;3(2):129-49
references.pmid: 6110810
references.citation: J Neurosci. 2001 Dec 15;21(24):9917-29
references.pmid: 11739599
references.citation: Ciba Found Symp. 1986;123:191-215
references.pmid: 3028724
references.citation: Neuroscience. 1998 Mar;83(1):63-79
references.pmid: 9466399
references.citation: Brain Res. 1998 Feb 2;783(1):115-20
references.pmid: 9479059
references.citation: Am J Psychiatry. 2004 Feb;161(2):195-216
references.pmid: 14754765
references.citation: Physiol Rev. 1992 Jan;72(1):165-229
references.pmid: 1731370
references.citation: J Comp Neurol. 2005 Nov 14;492(2):145-77
references.pmid: 16196030
references.citation: Ann N Y Acad Sci. 2006 Jul;1071:379-96
references.pmid: 16891584
references.citation: J Comp Neurol. 2004 Jan 19;468(4):518-29
references.pmid: 14689484
references.citation: Brain Res Bull. 2009 Mar 16;78(4-5):240-7
references.pmid: 19103268
references.citation: Neuroscience. 2008 Jul 17;154(4):1178-86
references.pmid: 18515010
references.citation: Brain Res. 2009 Aug 18;1285:109-18
references.pmid: 19524553